The tear film at the ocular surface is covered by a thin layer of lipids. This oily phase stabilizes the film by decreasing its surface tension and improving its viscoelastic properties. Clinically, destabilization and rupture of the tear film are related to dry eye disease and are accompanied by changes in the quality and quantity of tear film lipids. In dry eye, eye drops containing oil-in-water emulsions are used for the supplementation of lipids and surface-active components to the tear film. We explore in detail the biophysical aspects of interactions of specific surface-active compounds, cetalkonium chloride and poloxamer 188, which are present in oil-in-water emulsions, with tear lipids. The aim is to better understand the macroscopically observed eye drops-tear film interactions by rationalizing them at the molecular level. To this end, we employ a multi-scale approach combining experiments on human meibomian lipid extracts, measurements using synthetic lipid films, and in silico molecular dynamics simulations. By combining these methods, we demonstrate that the studied compounds specifically interact with the tear lipid film enhancing its structure, surfactant properties, and elasticity. The observed effects are cooperative and can be further modulated by material packing at the tear-air interface.

• Klíčová slova
• Langmuir trough, dilatation rheology, fluorescence microscopy, meibum, molecular dynamics, tear film, tear film lipid layer,
• MeSH
• fluorescenční mikroskopie * metody   MeSH
• kvartérní amoniové sloučeniny chemie   MeSH
• lidé MeSH
• lipidy * chemie   MeSH
• mastné alkoholy chemie   MeSH
• meibomské žlázky metabolismus   MeSH
• poloxamer chemie   MeSH
• simulace molekulární dynamiky * MeSH
• slzy * chemie   MeSH
• teoretické modely MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• cetalkonium chloride MeSH Prohlížeč
• kvartérní amoniové sloučeniny MeSH
• lipidy * MeSH
• mastné alkoholy MeSH
• poloxamer MeSH

Dry eye disease (DED) is a complex multifactorial disease that affects an increasing number of patients worldwide. Close to 30% of the population has experienced dry eye (DE) symptoms and presented with some signs of the disease during their lifetime. The significant heterogeneity in the medical background of patients with DEs and in their sensitivity to symptoms renders a clear understanding of DED complicated. It has become evident over the past few years that DED results from an impairment of the ocular surface homeostasis. Hence, a holistic treatment approach that concomitantly addresses the different mechanisms that result in the destabilization of the tear film (TF) and the ocular surface would be appropriate. The goal of the present review is to compile the different types of scientific evidence (from in silico modeling to clinical trials) that help explain the mechanism of action of cationic emulsion (CE)-based eye drop technology for the treatment of both the signs and the symptoms of DED. These CE-based artificial tear (AT) eye drops designed to mimic, from a functional point of view, a healthy TF contribute to the restoration of a healthy ocular surface environment and TF that leads to a better management of DE patients. The CE-based AT eye drops help restore the ocular surface homeostasis in patients who have unstable TF or no tears.

• Klíčová slova
• artificial tear, cationic emulsion, dry eye, polar lipid, tear film lipid layer,
• MeSH
• dospělí MeSH
• emulze chemie   farmakologie   MeSH
• homeostáza MeSH
• lidé MeSH
• oči - fyziologické jevy účinky léků   MeSH
• povrchové vlastnosti účinky léků   MeSH
• slzy fyziologie   MeSH
• syndromy suchého oka farmakoterapie   MeSH
• zdraví dobrovolníci pro lékařské studie statistika a číselné údaje   MeSH
• zvlhčující oční kapky aplikace a dávkování   chemie   terapeutické užití   MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• srovnávací studie MeSH
• Názvy látek
• emulze MeSH
• zvlhčující oční kapky MeSH